✦ LIBER ✦

Response of subcutaneous and cutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapy

✍ Scribed by M. HAHKA-KEMPPINEN; T. MUHONEN; M. VIROLAINEN; A. JEKUNEN; S. ASKO-SELTAVAARA; S. PYRHÖNEN

Book ID: 108666866
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 382 KB
Volume: 132
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.1995.tb16958.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brain metastases of metastatic malignant

Brain metastases of metastatic malignant melanoma: Response to DTIC and interferon-gamma

✍ Dirk Schadendorf; Margitta Worm; Beate M. Czarnetzki 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 397 KB

Expression of STAT1 and STAT2 in maligna

Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy

✍ Gregory B. Lesinski; Daniel Valentino; Erinn M. Hade; Susie Jones; Cynthia Magro 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 715 KB

Association of IL28B variants with respo

Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b

✍ Naoya Sakamoto; Mina Nakagawa; Yasuhito Tanaka; Yuko Sekine-Osajima; Mayumi Ueya 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract Genetic polymorphisms of the interleukin 28B (IL28B) locus are associated closely with outcomes of pegylated‐interferon (PEG‐IFN) plus ribavirin (RBV) combination therapy. The aim of this study was to investigate the relationship between IL28B polymorphism and responses to therapy in pa